{
  "paper_id": "PMC7237065",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237065/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1.",
      "caption": "Distinguishing screening from early diagnosis according to symptom onset (WHO Guide to Cancer Early Diagnosis 2017)",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/e385aa0e8702/nihms-1584218-f0001.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/e385aa0e8702/nihms-1584218-f0001.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/e385aa0e8702/nihms-1584218-f0001.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/e385aa0e8702/nihms-1584218-f0001.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/e385aa0e8702/nihms-1584218-f0001.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7237065/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/e385aa0e8702/nihms-1584218-f0001.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Figure 2. Overview of Implementation Phases for Early diagnosis and Detection Pathways.",
      "caption": "(δ) Pathology services as the basis for breast cancer diagnosis. (*) Regardless of age or domicile. (**) Some middle-income countries introduce clinical breast examination (CBE) combined with mammography to reduce mammography intensity or as stand-alone test for expanded age groups £) Systematic screening offered to women attending health services for any reason, including response to media campaigns promoting breast cancer early detection €) Definition of number of visits in the clinical pathway (one to three): screening, complementary studies, diagnosis. (ϕ) Organized screening as opposed to opportunistic screening. As early detection programs are successfully implemented, early diagnosis services need to be continually supported for all women.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/69535585f676/nihms-1584218-f0002.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/69535585f676/nihms-1584218-f0002.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/69535585f676/nihms-1584218-f0002.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/69535585f676/nihms-1584218-f0002.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/69535585f676/nihms-1584218-f0002.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7237065/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/69535585f676/nihms-1584218-f0002.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Figure 3b.",
      "caption": "Potential interventions to strengthen early diagnosis\n(WHO Guide to Cancer Early Diagnosis (2017)",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/7c21f3dbb643/nihms-1584218-f0004.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/7c21f3dbb643/nihms-1584218-f0004.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/7c21f3dbb643/nihms-1584218-f0004.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/7c21f3dbb643/nihms-1584218-f0004.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F4",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/7c21f3dbb643/nihms-1584218-f0004.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7237065/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/7c21f3dbb643/nihms-1584218-f0004.jpg"
    },
    "figure_4": {
      "figure_number": "Figure 4",
      "title": "Figure 4.",
      "caption": "Paradigm of early detection via population-based screening",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/0fe11e69575c/nihms-1584218-f0005.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/0fe11e69575c/nihms-1584218-f0005.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/0fe11e69575c/nihms-1584218-f0005.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/0fe11e69575c/nihms-1584218-f0005.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F5",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/0fe11e69575c/nihms-1584218-f0005.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7237065/images/figure_4.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/0fe11e69575c/nihms-1584218-f0005.jpg"
    },
    "figure_5": {
      "figure_number": "Figure 5",
      "title": "Figure 5.",
      "caption": "Universal patient pathway for breast cancer management in three sequential intervals of care (Patient Interval, Diagnostic Interval, and Treatment Interval) highlighting the Patient and Diagnostic Intervals of care. The Patient Interval begins with the onset of clinical symptoms or an abnormal screening exam and extends to the time the patient presents for diagnostic work-up of a recognized or suspected breast abnormality. During the Diagnostic Interval, the identified breast abnormality undergoes a ‘triple test’ work-up based on clinical evaluation, imaging and tissue sampling to achieve a definitive benign or malignant diagnosis. The health system should endeavor to complete the diagnostic work-up within a 60 day (2 month) period, because worsened survival outcomes can result from diagnostic delays extending significantly beyond 3 months.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/edc8756cf325/nihms-1584218-f0006.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/edc8756cf325/nihms-1584218-f0006.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/edc8756cf325/nihms-1584218-f0006.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/edc8756cf325/nihms-1584218-f0006.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F6",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/edc8756cf325/nihms-1584218-f0006.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7237065/images/figure_5.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e4/7237065/edc8756cf325/nihms-1584218-f0006.jpg"
    }
  },
  "claims": [
    {
      "sentence": "Here, we present “phases” of early detection program development, beginning with management strategies required for the diagnosis of clinically detectable disease, and address core issues pertaining to successful planning, implementation and the iterative process of program improvement, needed for a breast cancer early detection program to succeed in any resource setting.Introduction\nThe World Health Organisation has defined two distinct but related strategies to promote the early detection of cancer, early diagnosis, that is, the recognition of symptomatic cancer at an early stage; and screening, that is the identification of asymptomatic disease in a target population of apparently healthy individuals1 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents an overview of this approach, which is descibed in more detail in the subsequent sections.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 3 provides an overview of interventions or strategies to overcome common barriers to early diagnosis.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "20, 22, 25 However, for population-based screening with mammography to succeed in reducing mortality, many criteria must be met, including individual identification of every person in the target population, individual invitation, and individual follow-up throughout the whole clinical pathway to ensure access to the screening, diagnostic, and treatment procedures (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Basic components of breast cancer early detection policies comprise identifying the target population, defining the diagnostic tools, delineating the programmatic approaches, and elaborating the rollout and scale up process (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "While patient and health provider education may shorten the patient interval, in order to achieve a diagnostic interval target of less than 60 days requires coordination of the diagnostic pathway elements of clinical evaluation, imaging, tissue sampling and pathological assessment (Figure 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The health system should endeavor to complete the diagnostic work-up within a 60 day (2 month) period, because worsened survival outcomes can result from diagnostic delays extending significantly beyond 3 months.Figure 3b.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Here, we present “phases” of early detection program development, beginning with management strategies required for the diagnosis of clinically detectable disease, and address core issues pertaining to successful planning, implementation and the iterative process of program improvement, needed for a breast cancer early detection program to succeed in any resource setting.Introduction\nThe World Health Organisation has defined two distinct but related strategies to promote the early detection of cancer, early diagnosis, that is, the recognition of symptomatic cancer at an early stage; and screening, that is the identification of asymptomatic disease in a target population of apparently healthy individuals1 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents an overview of this approach, which is descibed in more detail in the subsequent sections.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 3 provides an overview of interventions or strategies to overcome common barriers to early diagnosis.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "20, 22, 25 However, for population-based screening with mammography to succeed in reducing mortality, many criteria must be met, including individual identification of every person in the target population, individual invitation, and individual follow-up throughout the whole clinical pathway to ensure access to the screening, diagnostic, and treatment procedures (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Basic components of breast cancer early detection policies comprise identifying the target population, defining the diagnostic tools, delineating the programmatic approaches, and elaborating the rollout and scale up process (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "While patient and health provider education may shorten the patient interval, in order to achieve a diagnostic interval target of less than 60 days requires coordination of the diagnostic pathway elements of clinical evaluation, imaging, tissue sampling and pathological assessment (Figure 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The health system should endeavor to complete the diagnostic work-up within a 60 day (2 month) period, because worsened survival outcomes can result from diagnostic delays extending significantly beyond 3 months.Figure 3b.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Here, we present “phases” of early detection program development, beginning with management strategies required for the diagnosis of clinically detectable disease, and address core issues pertaining to successful planning, implementation and the iterative process of program improvement, needed for a breast cancer early detection program to succeed in any resource setting.Introduction\nThe World Health Organisation has defined two distinct but related strategies to promote the early detection of cancer, early diagnosis, that is, the recognition of symptomatic cancer at an early stage; and screening, that is the identification of asymptomatic disease in a target population of apparently healthy individuals1 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents an overview of this approach, which is descibed in more detail in the subsequent sections.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 3 provides an overview of interventions or strategies to overcome common barriers to early diagnosis.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "20, 22, 25 However, for population-based screening with mammography to succeed in reducing mortality, many criteria must be met, including individual identification of every person in the target population, individual invitation, and individual follow-up throughout the whole clinical pathway to ensure access to the screening, diagnostic, and treatment procedures (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Basic components of breast cancer early detection policies comprise identifying the target population, defining the diagnostic tools, delineating the programmatic approaches, and elaborating the rollout and scale up process (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "While patient and health provider education may shorten the patient interval, in order to achieve a diagnostic interval target of less than 60 days requires coordination of the diagnostic pathway elements of clinical evaluation, imaging, tissue sampling and pathological assessment (Figure 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The health system should endeavor to complete the diagnostic work-up within a 60 day (2 month) period, because worsened survival outcomes can result from diagnostic delays extending significantly beyond 3 months.Figure 3b.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Here, we present “phases” of early detection program development, beginning with management strategies required for the diagnosis of clinically detectable disease, and address core issues pertaining to successful planning, implementation and the iterative process of program improvement, needed for a breast cancer early detection program to succeed in any resource setting.Introduction\nThe World Health Organisation has defined two distinct but related strategies to promote the early detection of cancer, early diagnosis, that is, the recognition of symptomatic cancer at an early stage; and screening, that is the identification of asymptomatic disease in a target population of apparently healthy individuals1 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents an overview of this approach, which is descibed in more detail in the subsequent sections.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 3 provides an overview of interventions or strategies to overcome common barriers to early diagnosis.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "20, 22, 25 However, for population-based screening with mammography to succeed in reducing mortality, many criteria must be met, including individual identification of every person in the target population, individual invitation, and individual follow-up throughout the whole clinical pathway to ensure access to the screening, diagnostic, and treatment procedures (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Basic components of breast cancer early detection policies comprise identifying the target population, defining the diagnostic tools, delineating the programmatic approaches, and elaborating the rollout and scale up process (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "While patient and health provider education may shorten the patient interval, in order to achieve a diagnostic interval target of less than 60 days requires coordination of the diagnostic pathway elements of clinical evaluation, imaging, tissue sampling and pathological assessment (Figure 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The health system should endeavor to complete the diagnostic work-up within a 60 day (2 month) period, because worsened survival outcomes can result from diagnostic delays extending significantly beyond 3 months.Figure 3b.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Here, we present “phases” of early detection program development, beginning with management strategies required for the diagnosis of clinically detectable disease, and address core issues pertaining to successful planning, implementation and the iterative process of program improvement, needed for a breast cancer early detection program to succeed in any resource setting.Introduction\nThe World Health Organisation has defined two distinct but related strategies to promote the early detection of cancer, early diagnosis, that is, the recognition of symptomatic cancer at an early stage; and screening, that is the identification of asymptomatic disease in a target population of apparently healthy individuals1 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents an overview of this approach, which is descibed in more detail in the subsequent sections.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 3 provides an overview of interventions or strategies to overcome common barriers to early diagnosis.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "20, 22, 25 However, for population-based screening with mammography to succeed in reducing mortality, many criteria must be met, including individual identification of every person in the target population, individual invitation, and individual follow-up throughout the whole clinical pathway to ensure access to the screening, diagnostic, and treatment procedures (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Basic components of breast cancer early detection policies comprise identifying the target population, defining the diagnostic tools, delineating the programmatic approaches, and elaborating the rollout and scale up process (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "While patient and health provider education may shorten the patient interval, in order to achieve a diagnostic interval target of less than 60 days requires coordination of the diagnostic pathway elements of clinical evaluation, imaging, tissue sampling and pathological assessment (Figure 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The health system should endeavor to complete the diagnostic work-up within a 60 day (2 month) period, because worsened survival outcomes can result from diagnostic delays extending significantly beyond 3 months.Figure 3b.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Here, we present “phases” of early detection program development, beginning with management strategies required for the diagnosis of clinically detectable disease, and address core issues pertaining to successful planning, implementation and the iterative process of program improvement, needed for a breast cancer early detection program to succeed in any resource setting.Introduction\nThe World Health Organisation has defined two distinct but related strategies to promote the early detection of cancer, early diagnosis, that is, the recognition of symptomatic cancer at an early stage; and screening, that is the identification of asymptomatic disease in a target population of apparently healthy individuals1 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents an overview of this approach, which is descibed in more detail in the subsequent sections.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 3 provides an overview of interventions or strategies to overcome common barriers to early diagnosis.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "20, 22, 25 However, for population-based screening with mammography to succeed in reducing mortality, many criteria must be met, including individual identification of every person in the target population, individual invitation, and individual follow-up throughout the whole clinical pathway to ensure access to the screening, diagnostic, and treatment procedures (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Basic components of breast cancer early detection policies comprise identifying the target population, defining the diagnostic tools, delineating the programmatic approaches, and elaborating the rollout and scale up process (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "While patient and health provider education may shorten the patient interval, in order to achieve a diagnostic interval target of less than 60 days requires coordination of the diagnostic pathway elements of clinical evaluation, imaging, tissue sampling and pathological assessment (Figure 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The health system should endeavor to complete the diagnostic work-up within a 60 day (2 month) period, because worsened survival outcomes can result from diagnostic delays extending significantly beyond 3 months.Figure 3b.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Here, we present “phases” of early detection program development, beginning with management strategies required for the diagnosis of clinically detectable disease, and address core issues pertaining to successful planning, implementation and the iterative process of program improvement, needed for a breast cancer early detection program to succeed in any resource setting.Introduction\nThe World Health Organisation has defined two distinct but related strategies to promote the early detection of cancer, early diagnosis, that is, the recognition of symptomatic cancer at an early stage; and screening, that is the identification of asymptomatic disease in a target population of apparently healthy individuals1 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents an overview of this approach, which is descibed in more detail in the subsequent sections.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 3 provides an overview of interventions or strategies to overcome common barriers to early diagnosis.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "20, 22, 25 However, for population-based screening with mammography to succeed in reducing mortality, many criteria must be met, including individual identification of every person in the target population, individual invitation, and individual follow-up throughout the whole clinical pathway to ensure access to the screening, diagnostic, and treatment procedures (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Basic components of breast cancer early detection policies comprise identifying the target population, defining the diagnostic tools, delineating the programmatic approaches, and elaborating the rollout and scale up process (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "While patient and health provider education may shorten the patient interval, in order to achieve a diagnostic interval target of less than 60 days requires coordination of the diagnostic pathway elements of clinical evaluation, imaging, tissue sampling and pathological assessment (Figure 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The health system should endeavor to complete the diagnostic work-up within a 60 day (2 month) period, because worsened survival outcomes can result from diagnostic delays extending significantly beyond 3 months.Figure 3b.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Here, we present “phases” of early detection program development, beginning with management strategies required for the diagnosis of clinically detectable disease, and address core issues pertaining to successful planning, implementation and the iterative process of program improvement, needed for a breast cancer early detection program to succeed in any resource setting.Introduction\nThe World Health Organisation has defined two distinct but related strategies to promote the early detection of cancer, early diagnosis, that is, the recognition of symptomatic cancer at an early stage; and screening, that is the identification of asymptomatic disease in a target population of apparently healthy individuals1 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents an overview of this approach, which is descibed in more detail in the subsequent sections.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 3 provides an overview of interventions or strategies to overcome common barriers to early diagnosis.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "20, 22, 25 However, for population-based screening with mammography to succeed in reducing mortality, many criteria must be met, including individual identification of every person in the target population, individual invitation, and individual follow-up throughout the whole clinical pathway to ensure access to the screening, diagnostic, and treatment procedures (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Basic components of breast cancer early detection policies comprise identifying the target population, defining the diagnostic tools, delineating the programmatic approaches, and elaborating the rollout and scale up process (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "While patient and health provider education may shorten the patient interval, in order to achieve a diagnostic interval target of less than 60 days requires coordination of the diagnostic pathway elements of clinical evaluation, imaging, tissue sampling and pathological assessment (Figure 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The health system should endeavor to complete the diagnostic work-up within a 60 day (2 month) period, because worsened survival outcomes can result from diagnostic delays extending significantly beyond 3 months.Figure 3b.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Introduction\nThe World Health Organisation has defined two distinct but related strategies to promote the early detection of cancer, early diagnosis, that is, the recognition of symptomatic cancer at an early stage; and screening, that is the identification of asymptomatic disease in a target population of apparently healthy individuals1 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents an overview of this approach, which is descibed in more detail in the subsequent sections.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The World Health Organisation has defined two distinct but related strategies to promote the early detection of cancer, early diagnosis, that is, the recognition of symptomatic cancer at an early stage; and screening, that is the identification of asymptomatic disease in a target population of apparently healthy individuals1 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents an overview of this approach, which is descibed in more detail in the subsequent sections.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 3 provides an overview of interventions or strategies to overcome common barriers to early diagnosis.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "20, 22, 25 However, for population-based screening with mammography to succeed in reducing mortality, many criteria must be met, including individual identification of every person in the target population, individual invitation, and individual follow-up throughout the whole clinical pathway to ensure access to the screening, diagnostic, and treatment procedures (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Figure 3 provides an overview of interventions or strategies to overcome common barriers to early diagnosis.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 3 provides an overview of interventions or strategies to overcome common barriers to early diagnosis.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "20, 22, 25 However, for population-based screening with mammography to succeed in reducing mortality, many criteria must be met, including individual identification of every person in the target population, individual invitation, and individual follow-up throughout the whole clinical pathway to ensure access to the screening, diagnostic, and treatment procedures (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "20, 22, 25 However, for population-based screening with mammography to succeed in reducing mortality, many criteria must be met, including individual identification of every person in the target population, individual invitation, and individual follow-up throughout the whole clinical pathway to ensure access to the screening, diagnostic, and treatment procedures (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Basic components of breast cancer early detection policies comprise identifying the target population, defining the diagnostic tools, delineating the programmatic approaches, and elaborating the rollout and scale up process (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Basic components of breast cancer early detection policies comprise identifying the target population, defining the diagnostic tools, delineating the programmatic approaches, and elaborating the rollout and scale up process (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Basic components of breast cancer early detection policies comprise identifying the target population, defining the diagnostic tools, delineating the programmatic approaches, and elaborating the rollout and scale up process (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "While patient and health provider education may shorten the patient interval, in order to achieve a diagnostic interval target of less than 60 days requires coordination of the diagnostic pathway elements of clinical evaluation, imaging, tissue sampling and pathological assessment (Figure 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "While patient and health provider education may shorten the patient interval, in order to achieve a diagnostic interval target of less than 60 days requires coordination of the diagnostic pathway elements of clinical evaluation, imaging, tissue sampling and pathological assessment (Figure 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 5,
    "claims_count": 71,
    "images_downloaded": 5,
    "tables_filtered": 4
  }
}